EMEA-002457-PIP01-18

Key facts

Active substance
Emricasan
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0230/2019
PIP number
EMEA-002457-PIP01-18
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of non-alcoholic steatohepatitis (NASH)
Route(s) of administration
Oral use
Contact for public enquiries
Conatus Pharmaceuticals, Inc.

16745 West Bernardo Drive, San Diego
California 92127
U.S.A.
E-mail: aspada@conatuspharma.com
Tel.: +1 858-376-2623

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating